971 related articles for article (PubMed ID: 19762090)
21. Cardiomyocyte differentiation from embryonic and adult stem cells.
Passier R; Mummery C
Curr Opin Biotechnol; 2005 Oct; 16(5):498-502. PubMed ID: 16099156
[TBL] [Abstract][Full Text] [Related]
22. Human embryonic stem cells for cardiomyogenesis.
Habib M; Caspi O; Gepstein L
J Mol Cell Cardiol; 2008 Oct; 45(4):462-74. PubMed ID: 18775434
[TBL] [Abstract][Full Text] [Related]
23. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes.
Lev S; Kehat I; Gepstein L
Ann N Y Acad Sci; 2005 Jun; 1047():50-65. PubMed ID: 16093484
[TBL] [Abstract][Full Text] [Related]
24. The significance of induced pluripotent stem cells for basic research and clinical therapy.
Meyer JR
J Med Ethics; 2008 Dec; 34(12):849-51. PubMed ID: 19043107
[TBL] [Abstract][Full Text] [Related]
25. ES and iPS cell research for cardiovascular regeneration.
Yamashita JK
Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
[TBL] [Abstract][Full Text] [Related]
26. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.
Davis RP; van den Berg CW; Casini S; Braam SR; Mummery CL
Trends Mol Med; 2011 Sep; 17(9):475-84. PubMed ID: 21703926
[TBL] [Abstract][Full Text] [Related]
27. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.
Yokoo N; Baba S; Kaichi S; Niwa A; Mima T; Doi H; Yamanaka S; Nakahata T; Heike T
Biochem Biophys Res Commun; 2009 Sep; 387(3):482-8. PubMed ID: 19615974
[TBL] [Abstract][Full Text] [Related]
28. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
Romano G
Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
[TBL] [Abstract][Full Text] [Related]
29. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
[TBL] [Abstract][Full Text] [Related]
30. Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
Sartipy P; Bjorquist P; Strehl R; Hyllner J
IDrugs; 2006 Oct; 9(10):702-5. PubMed ID: 17016777
[TBL] [Abstract][Full Text] [Related]
31. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
Salewski RP; Eftekharpour E; Fehlings MG
J Cell Physiol; 2010 Mar; 222(3):515-21. PubMed ID: 20020443
[TBL] [Abstract][Full Text] [Related]
32. Protocols for cardiac differentiation of embryonic stem cells.
Pucéat M
Methods; 2008 Jun; 45(2):168-71. PubMed ID: 18593613
[TBL] [Abstract][Full Text] [Related]
33. Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?
Ensenat-Waser R; Pellicer A; Simon C
Fertil Steril; 2009 Apr; 91(4):971-4. PubMed ID: 19200985
[TBL] [Abstract][Full Text] [Related]
34. Cardiomyocytes derived from stem cells.
Van Laake LW; Van Hoof D; Mummery CL
Ann Med; 2005; 37(7):499-512. PubMed ID: 16278163
[TBL] [Abstract][Full Text] [Related]
35. Human pluripotent stem cells: decoding the naïve state.
Li W; Ding S
Sci Transl Med; 2011 Mar; 3(76):76ps10. PubMed ID: 21451122
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
[TBL] [Abstract][Full Text] [Related]
37. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
Li W; Ding S
Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
[TBL] [Abstract][Full Text] [Related]
38. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.
Lui KO; Bu L; Li RA; Chan CW
Birth Defects Res C Embryo Today; 2012 Mar; 96(1):98-108. PubMed ID: 22457181
[TBL] [Abstract][Full Text] [Related]
39. Human embryonic stem cell technologies and drug discovery.
Jensen J; Hyllner J; Björquist P
J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
[TBL] [Abstract][Full Text] [Related]
40. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
Amabile G; Meissner A
Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
